Test 162.
Predictive marker for targeted therapy in chronic lymphocytic leukemia (CLL)
Duplications/ deletions of 17p13 (TP53 gene), 13q14 (RB1/DLEU/MIR15A-region), 11q22 (ATM, trisomy 12)
RDX, CADM1, PPP2R1B, DLEU1/2/7, KCNRG, MIR15A, ATM, PTEN, TP53, RB1